EyeCare Partners Unveils 2024 Quality and Outcomes Report, Highlighting Superior Patient Care and Innovative Research

EyeCare Partners (ECP), the leading provider of clinically integrated eye care in the United States, has released its inaugural Quality and Outcomes Report, which highlights the organization's significant achievements in clinical excellence, innovation, research, and patient outcomes for the year 2024. The report underscores a transformative period for ECP, demonstrating its commitment to delivering high-quality, patient-centered care through a national network of over 1,000 eye care providers. In 2024, ECP recorded over 2.4 million patient encounters and performed more than 260,000 surgeries. These figures showcase the organization's role as a benchmark in integrated eye care, driven by superior quality and patient satisfaction metrics. "The release of our first Quality and Outcomes Report is a defining moment for EyeCare Partners," said Dr. Antonio Capone, Jr., Chief Clinical Officer. "This document isn’t simply a compilation of numbers; it’s a testament to our dedication to clinical excellence, innovation, and transparency, all made possible by the hard work and dedication of our team members. By integrating insights, we are enhancing current outcomes and setting the stage for the future of eye health." Key highlights from the report include: Strong Clinical Outcomes: - Cataract surgery patients achieved 20/40 vision or better at a rate of 94% across all regions, surpassing national benchmarks. - Complication rates for both cataract and retina procedures were notably lower than national averages. World-Class Patient Experience: - ECP received impressive Net Promoter Scores of +89 in ophthalmology and +84 in optometry. - Google review ratings stood at 4.9 stars for ophthalmology and 4.6 stars for optometry, reflecting high levels of patient satisfaction. Data-Driven Innovation: - The EyeCare Partners Innovation Center (EPIC) enhanced its data infrastructure, consolidating over 6 million patient records. - A Clinical Data Warehouse was launched to support ongoing research and quality improvement initiatives. Research Leadership: - ECP participated in more than 500 clinical trials in 2024, focusing on advanced treatments such as sustained drug delivery for age-related macular degeneration and glaucoma, as well as regenerative therapies for corneal edema. Education and Workforce Development: - ECP introduced the Refractive Cataract Anterior Segment Fellowship to train the next generation of eye care professionals. - The organization also supported various residency and externship programs, further contributing to the growth of the field. Community Impact: - The ECP Foundation provided over $175,000 in crisis relief to employees. - More than 7,000 eyeglass frames were donated to underserved children. - Team members engaged in global mission trips and local charitable care initiatives, making a tangible difference in the communities they serve. "Through this report, we aim to highlight the strength of physician-led care and our commitment to data-driven innovation," said Chris Throckmorton, Chief Executive Officer. "We are proud of these results and enthusiastic about the future we are collectively shaping to enhance and protect vision." For a detailed look at the 2024 Quality and Outcomes Report, visit www.eyecare-partners.com. About EyeCare Partners: EyeCare Partners is the premier provider of clinically integrated eye care in the United States. Their extensive national network, comprising over 300 ophthalmologists and 700 optometrists, offers comprehensive eye care services with a mission to enhance vision, advance eye care, and improve lives. Headquartered in St. Louis, Missouri, ECP operates in over 700 practice locations across 18 states and 30 markets. For more information, visit their website at www.eyecare-partners.com, and connect with them on LinkedIn, Instagram, and Facebook.